Aytu Biopharma (AYTU) Shares Outstanding (Diluted Average) (2020 - 2026)

Aytu Biopharma (AYTU) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $10.5 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $10.5 million, up 22.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 22.14% YoY), and the FY2023 annual result was $3.3 million, up 127.22% from the prior year.
• Shares Outstanding (Diluted Average) rose to $10.5 million in Q1 2026 per AYTU's latest filing, from $10.0 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $19.5 million in Q3 2025 and troughed at $1.4 million in Q1 2022.
• A 5-year average of $6.6 million and a median of $5.5 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) sank 91.22% in 2022, then soared 173.91% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $3.1 million in 2022, then surged by 77.4% to $5.5 million in 2023, then soared by 53.78% to $8.5 million in 2024, then climbed by 18.28% to $10.0 million in 2025, then increased by 4.74% to $10.5 million in 2026.
• Business Quant data shows AYTU's Shares Outstanding (Diluted Average) at $10.5 million in Q1 2026, $10.0 million in Q4 2025, and $19.5 million in Q3 2025.